Clinical Trial Update: PSMA-PET Guided Radiotherapy [Phase 2, Phase 3]

View source ↗

Summary

This entry describes an ongoing Phase 2/3 trial evaluating PSMA-PET guided radiotherapy for prostate cancer, with the study currently listed as active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING